-
Mashup Score: 3
Thromboprophylaxis of hospitalized patients at risk of venous thromboembolism (VTE) presents challenges owing to patient heterogeneity and lack of adoption of evidence-based methods. Intuitive practices for thromboprophylaxis have resulted in many patients being inappropriately prophylaxed. We conducted a narrative review summarizing system-wide thromboprophylaxis interventions in hospitalized patients. Multiple interventions for thromboprophylaxis have been tested, including multifaceted approaches such as national VTE prevention programs with audits, pre-printed order entry, passive alerts (either human or electronic), and more recently, the use of active clinical decision support (CDS) tools incorporated into electronic health records (EHRs). Multifaceted health-system and order entry interventions have shown mixed results in their ability to increase appropriate thromboprophylaxis and reduce VTE unless mandated through a national VTE prevention program, though the latter approach i
Source: www.mdpi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24International Angiology 2024 February;43(1):1-222 - 1 month(s) ago
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence
Source: www.minervamedica.itCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21International Angiology 2024 February;43(1):1-222 - 2 month(s) ago
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence
Source: www.minervamedica.itCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 40Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence - PubMed - 2 month(s) ago
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36Procedure Playbook | North American Thrombosis Forum - 3 month(s) ago
The NATF Procedure Playbook was developed for people who take medicine to prevent blood clots and need a planned surgery or procedure.
Source: thrombosis.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 33Procedure Playbook | North American Thrombosis Forum - 3 month(s) ago
The NATF Procedure Playbook was developed for people who take medicine to prevent blood clots and need a planned surgery or procedure.
Source: thrombosis.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial - PubMed - 3 month(s) ago
ANZCTR Identifier: ACTRN12618000811202.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18Antithrombotic prophylaxis with rivaroxaban in patients with prehospital COVID-19: A meta-analysis of two placebo-controlled trials - PubMed - 5 month(s) ago
Background We conducted a prespecified meta-analysis of two randomized, placebo-controlled trials of rivaroxaban 10 mg daily in prehospital patients with acute COVID-19. Individually, the trials had limited power to detect a treatment effect due to recruitment stopping ahead of plan. Methods The sta …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York - 6 month(s) ago
COVID-19 is a challenging disease to characterize given its wide-ranging heterogeneous symptomatology. Several studies have attempted to extract clini…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer - PubMed - 6 month(s) ago
Patients with active cancer were older (p < 0.001), more likely to be thrombocytopenic (p = 0.026), have moderate renal dysfunction (p = 0.005) and were more likely to receive lower-dose DOAC therapy (p < 0.001). A greater proportion of patients with active cancer underwent a high-bleed-risk p …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
Electronic Health-Record Agnostic #Clinical Decision Support most effective system-wide intervention to ↑ #thromboprophylaxis and ↓ #thrombosis https://t.co/88Oo6OweeF #mdpijcm via @JCM_MDPI @NATFthrombosis @AnticoagForum @PERTConsortium @ThrombosisCan @canvector @ThrombosisUK